Viral Engineering

Viral Engineering is a methodological approach in oncolytic virus immunotherapy that involves the deliberate modification of viral genomes to enhance tumor selectivity, immune activation, and therapeutic efficacy while preserving viral replication capacity.

767

Publications

40.2K

Citations

4.4K

Authors

963

Institutions

Publications per year

2017–2026

173

Authors

4.4K

  1. SJ
    Stephen J. Russell

    Mayo Clinic, United States

    22 publications · 1.2K citations

    18

    h-index

  2. YF
    Yuman Fong

    Memorial Sloan Kettering Cancer Center, United States

    18 publications · 629 citations

    15

    h-index

  3. JC
    John C. Bell

    University of Ottawa, Canada

    15 publications · 1.5K citations

    15

    h-index

  4. GY
    G. Yancey Gillespie

    University of Alabama at Birmingham, United States

    13 publications · 1.1K citations

    12

    h-index

  5. AH
    Akseli Hemminki

    University of Helsinki, Finland

    12 publications · 823 citations

    12

    h-index

1–5 of 4.4K

Venues

  1. Journal of Virology

    JVI · 77 publications · 4.8K citations

    38

    h-index

  2. Molecular Therapy

    47 publications · 3.3K citations

    32

    h-index

  3. Gene Therapy

    43 publications · 2K citations

    28

    h-index

  4. PubMed

    Repository · 42 publications · 3.2K citations

    28

    h-index

  5. Human Gene Therapy

    37 publications · 1.8K citations

    26

    h-index

1–5